206 related articles for article (PubMed ID: 16164907)
1. The Vioxx debacle revisited.
Abeles M; Abeles AM
Am J Med; 2005 Sep; 118(9):1057-8. PubMed ID: 16164907
[No Abstract] [Full Text] [Related]
2. Concerns about COX-2 painkillers. They're easier on the stomach, potentially harder on your heart.
Heart Advis; 2002 Jan; 5(1):2. PubMed ID: 16145759
[No Abstract] [Full Text] [Related]
3. Painful lessons.
Nat Struct Mol Biol; 2005 Mar; 12(3):205. PubMed ID: 15744317
[No Abstract] [Full Text] [Related]
4. Summaries for patients. Cyclooxygenase-2 inhibitors and heart attacks: varying effects?
Ann Intern Med; 2005 Feb; 142(3):I21. PubMed ID: 15684199
[No Abstract] [Full Text] [Related]
5. What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex).
Wooltorton E
CMAJ; 2002 Jun; 166(13):1692-3. PubMed ID: 12126328
[No Abstract] [Full Text] [Related]
6. Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors.
Drago F; Brusati C; Desirello G; Cacciapuoti M; Rebora A
J Am Acad Dermatol; 2004 Dec; 51(6):1029-30. PubMed ID: 15583611
[No Abstract] [Full Text] [Related]
7. Is concern about cardiovascular events with the new coxib class of drugs justified?
Schnitzer TJ
Medscape Womens Health; 2001 Oct; 6(5):8. PubMed ID: 11698930
[No Abstract] [Full Text] [Related]
8. Celecoxib shown effective in preventing colon polyps.
Nelson NJ
J Natl Cancer Inst; 2006 May; 98(10):665-7. PubMed ID: 16705118
[No Abstract] [Full Text] [Related]
9. [Vision impairment by COX-2 inhibitor and the sequelae of voluntary Vioxx recall].
Meyer CH
Klin Monbl Augenheilkd; 2005 Jan; 222(1):62-3. PubMed ID: 15678404
[No Abstract] [Full Text] [Related]
10. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)].
Zeidler H
MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521
[No Abstract] [Full Text] [Related]
11. COX-2 selective inhibitors--important lessons learned.
Maxwell SR; Webb DJ
Lancet; 2005 Feb 5-11; 365(9458):449-51. PubMed ID: 15705439
[No Abstract] [Full Text] [Related]
12. Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction.
Jugdutt BI
Circulation; 2007 Jan; 115(3):288-91. PubMed ID: 17242292
[No Abstract] [Full Text] [Related]
13. The Vioxx debacle revisited.
Daikh DI
Am J Med; 2005 Sep; 118(9):1057. PubMed ID: 16164908
[No Abstract] [Full Text] [Related]
14. Cardiovascular risk associated with celecoxib.
Brophy JM
N Engl J Med; 2005 Jun; 352(25):2648-50; author reply 2648-50. PubMed ID: 15972876
[No Abstract] [Full Text] [Related]
15. Cyclooxygenase-2 inhibitors and cardiovascular risk.
Smith ER
Can J Cardiol; 2005 Mar; 21(3):307-8. PubMed ID: 15776124
[No Abstract] [Full Text] [Related]
16. Merck VIOXX "warning" is questioned.
Allen TS; Henderson JH
Tex Med; 2005 May; 101(5):5-6. PubMed ID: 15948521
[No Abstract] [Full Text] [Related]
17. [Cyclooxygenase-2 inhibitors and the ethics of research].
Gherardi CR
Medicina (B Aires); 2005; 65(5):476. PubMed ID: 16296649
[No Abstract] [Full Text] [Related]
18. The Vioxx debacle revisited.
Manthous CA
Am J Med; 2005 Sep; 118(9):1056-7; author reply 1057. PubMed ID: 16164904
[No Abstract] [Full Text] [Related]
19. The Vioxx debacle revisited.
Mohapatra PR; Janmeja AK
Am J Med; 2005 Sep; 118(9):1058. PubMed ID: 16164909
[No Abstract] [Full Text] [Related]
20. Trying times for painkiller choices. Vioxx, Bextra, and Celebrex can increase the risk for heart attack and other cardiovascular problems. So can the old standbys, like ibuprofen and acetaminophen.
Harv Heart Lett; 2006 Oct; 17(2):1-3. PubMed ID: 17153752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
